Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0005
-0.0001 (-16.67%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Q BioMed Employees
As of November 30, 2021, Q BioMed had 9 total employees, including 3 full-time and 6 part-time employees. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
$1,671
Profits / Employee
$164,007
Market Cap
72.55K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
QBIO News
- 1 year ago - Q BioMed Inc. Provides Update to Shareholders - PRNewsWire
- 1 year ago - Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe - PRNewsWire
- 1 year ago - Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office - PRNewsWire
- 1 year ago - Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC. - PRNewsWire
- 1 year ago - Q BIOMED PROVIDES SHAREHOLDER UPDATE - PRNewsWire
- 1 year ago - Q BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKER - PRNewsWire
- 2 years ago - Traders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc. - Accesswire
- 2 years ago - Q BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar Markets - PRNewsWire